丹参酮ⅡA磺酸钠注射液治疗冠心病、心绞痛的临床观察  

Clinical Observation on Sulfotanshinone Sodium Injection treating angina pectoris

作　　者：程峰[1] 杨凌飞[1] 

机构地区：[1]安徽省芜湖市皖南医学院附属第二医院心内科,芜湖241000

出　　处：《北方药学》2013年第9期56-57,共2页Journal of North Pharmacy

摘　　要：目的:观察丹参酮ⅡA磺酸钠注射液治疗冠心病、心绞痛的临床疗效。方法:丹参酮IIA磺酸钠注射液20ml加5%葡萄糖250ml静滴,每日一次,疗程14天。结果:心绞痛症状显著缓解,总有效率达95%。缺血性心电图明显改善(P<0.01)。心泵功能明显改善(P<0.05),血流变学明显改善(P<0.01)。结论:丹参酮IIA磺酸钠注射液治疗冠心病、心绞痛有显著疗效。Objective：To observe the Clinical effect of Sulfotanshinone Sodium Injection in treating angina pectoris.Methods：Sulfotanshinone Sodium Injection 20ml in5% glucose 250ml ivdrop once a day,last 14 days.Results： angina pectoris symptoms were significantly relieved.Total effective rate was 95% lschemic electroardiogram had significant improvement （P〈0.01）,so did heart function（P〈0.05）,so did hemorrheology（P〈0.01）.Conclusions：Sulfotanshinone Sodium Injection has significant therapeutic effect in treating angina pectoris.

关 键 词：丹参酮IIA磺酸钠 冠心病 心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]